MERCK CO. DL-,01 (6MK.DE) Financials
6MK.DE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 106.7 billion | 69.0 billion |
| 2023-09-30 | 106.7 billion | 65.4 billion |
| 2023-06-30 | 104.5 billion | 65.7 billion |
| 2023-03-31 | 107.8 billion | 60.9 billion |
6MK.DE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -743.0 million | 167.0 million |
| 2023-09-30 | 6.8 billion | 164.0 million |
| 2023-06-30 | 2.7 billion | 169.0 million |
| 2023-03-31 | 332.0 million | 145.0 million |
6MK.DE Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | -1.2 billion |
| 2023-09-30 | 4.8 billion |
| 2023-06-30 | -6.0 billion |
| 2023-03-31 | 2.8 billion |
6MK.DE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 7.1 billion | - | - |
| 2023-09-30 | 8.8 billion | - | - |
| 2023-06-30 | 6.4 billion | - | - |
| 2023-03-31 | 10.4 billion | - | - |
6MK.DE Shares Outstanding
6MK.DE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 989.0 million | 9.6 billion | 2.8 billion | - |
| 2023-09-30 | 902.0 million | 3.3 billion | 2.5 billion | - |
| 2023-06-30 | 965.0 million | 13.3 billion | 2.7 billion | - |
| 2023-03-31 | 1.0 billion | 4.3 billion | 2.5 billion | - |
6MK.DE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 14.6 billion | 3.9 billion |
| 2023-09-30 | 16.0 billion | 4.3 billion |
| 2023-06-30 | 15.0 billion | 4.0 billion |
| 2023-03-31 | 14.5 billion | 3.9 billion |
6MK.DE
Price: €120
Dividend Yield: 0.02%
Forward Dividend Yield: 2.39%
Payout Ratio: 2184.62%
Dividend Per Share: 2.84 EUR
Earnings Per Share: 0.83 EUR
P/E Ratio: 913.85
Exchange: GER
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 311.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 25
DGR3: 9.59%
DGR5: 11.22%
DGR10: 7.76%
DGR20: 30.00%